Financials
Financial year 2023
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
Revenue
€ 5.1 million
▼ 21% vs 2022
Profit
Caution€ -261.8 million
▼ 45% vs 2022
Debts
High€ 345,055
▼ 100% vs 2022
BIOCARTIS GROUP from Antwerpen, company number BE0505640808, closed financial year 2023 with a result of € -261.8 million after tax. For that financial year BIOCARTIS GROUP recorded revenue of € 5.1 million and equity of € -420,440. Compared with financial year 2022, the result moved from € -180.7 million to € -261.8 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2025.
What happened at BIOCARTIS GROUP?
What happened at BIOCARTIS GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2023: loss of € 261.8 million. filed late Source: NBB ↗
- Luc Gijssens BV stepped down as director. NBB
- Ann-Christine Sundell stepped down as director. NBB
- Christine Kuslich stepped down as director. NBB
- Bryan Dechairo stepped down as director. NBB
- Bryan Dechairo became a director. NBB
- Roald Borré stepped down as director. NBB
- Christine Kuslich became a director. NBB
In short
From € 34.1 million loss in 2021 to € 261.8 million loss in 2023.
Paid € 10,505 in corporate taxes since 2021.
Pays suppliers within 50 days on average.
A new publication or filing at BIOCARTIS GROUP? We notify you, reason included.
Follow BIOCARTIS GROUPNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind BIOCARTIS GROUP are South Bay Ventures BV and Christian Reinaudo. The shares are held by Invesco Ltd. (9.8%), Federale Participatie- en Investeringsmaatschappij (7.2%), UBS Group AG (4.5%), Credit Suisse Group AG (4.3%) and Johnson & Johnson Innovation - JJDC, Inc. (4.1%). It owns 50% of Wondfo-Cartis Limited itself.
Directors
According to the 2023 annual accounts
Director · represented by Herman Verrelst
Also active at: BIOCARTIS, OPDORP FINANCE
since 2022
since 2021
Christine Kuslich
Director
since 2022 · until 2025
Bryan Dechairo
Director
since 2023 · until 2024
Director · represented by Luc Gijssens
Also active at: GLOBAL RENTAL PROPERTIES, Serax Immo, Arvesta +4 more
since 2022 · until 2025
since 2022 · until 2023
Ann-Christine Sundell
Director
since 2022 · until 2025
Shareholders
Invesco Ltd.
9.8%
UBS Group AG
4.5%
Credit Suisse Group AG
4.3%
Johnson & Johnson Innovation - JJDC, Inc.
4.1%
Participations
Wondfo-Cartis Limited
50%
Establishments
Establishment units
Physical locations of this company
Potvlietlaan 6
2600 Antwerpen
Generaal De Wittelaan 11
2800 Mechelen
Active since 24 November 2014
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
Advocatenkantoor Yannick Grauwels
€ 108,291 gross margin · 2025
Mann + Hummel Hydromation
€ -23,495 gross margin · 2025
DELTA - ALPHA
€ 1.1 million gross margin · 2025
NATHACO
€ 60,061 gross margin · 2025
LINK 26
+11 more
Details
- Company number
- 0505.640.808
- VAT number
- BE 0505.640.808
- Registered office
- Potvlietlaan 6, 2600 Antwerpen
- Names & denominations
- BIOCARTIS GROUP
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Gerechtelijke ontbinding of nietigheid
- Start date
- 24 November 2014
- Peppol
- Active · Active since 1 Jan 2001